| Dose Escalation Study to Evaluate the Safety/Tolerability and Efficacy of EA-2353 in Subjects With Retinitis Pigmentosa (NCT05392751) | Endogena Therapeutics, Inc | 2022-06-02 |
| To Evaluate the PK, PD, Safety and Drug Tolerance in Healthy Volunteers (NCT05433844) | JW Pharmaceutical | 2022-06-02 |
| Trial of Chiauranib Capsule on Pharmacokinetics to Assess the Effect of High Fat Diet in Healthy Volunteers (NCT05346601) | Chipscreen Biosciences, Ltd. | 2022-06-02 |
| A Study of IMC-002 in Patients With Advanced Cancer Failed to Standard Therapy (NCT05276310) | ImmuneOncia Therapeutics Inc. | 2022-06-02 |
| A Study of LY3457263 Alone and in Combination With Dulaglutide (LY2189265) in Participants With Type 2 Diabetes (NCT05377333) | Eli Lilly and Company | 2022-06-02 |
| Actinium 225 Labeled Anti-CEA Antibody (Ac225-DOTA-M5A) for the Treatment of CEA Producing Advanced or Metastatic Cancers (NCT05204147) | City of Hope Medical Center | 2022-06-02 |
| A Study to Test How Well Different Doses of BI 765845 Are Tolerated by Healthy People (NCT06139315) | Boehringer Ingelheim | 2022-06-02 |
| Study of AZD5305 When Given in Combination With New Hormonal Agents in Patients With Metastatic Prostate Cancer (NCT05367440) | AstraZeneca | 2022-06-02 |
| Safety & PK of Single Doses of MT1980 (NCT05429840) | Monument Therapeutics Limited | 2022-06-01 |
| Fexofenadine in Patients With Active Rheumatoid Arthritis (NCT05264025) | October 6 University | 2022-06-01 |
| Group-Based Online Virtual Reality Gaming to Improve Mental Health Among Children With Physical Disabilities (NCT05259462) | University of Alabama at Birmingham | 2022-06-01 |
| Phase 1 Study of Oral RH324 in Advanced Non-Small Cell Lung Cancer (NCT05580172) | ReHeva Biosciences,Inc. | 2022-06-01 |
| Nilotinib Plus Dabrafenib/Trametinib or Encorafenib/Binimetinib in Metastatic Melanoma (NCT04903119) | Rina Plattner | 2022-06-01 |
| Improving the Function of the Foot by Core Foot System (CFS) Exercise Theory in Patients After Hallux Valgus Surgical Procedure (NCT05210127) | Józef Piłsudski University of Physical Education | 2022-06-01 |
| A Study of Maprotiline in Combination With Tamoxifen and Temozolomide for Recurrent Glioblastoma (NCT04200066) | University of Rochester | 2022-06-01 |
| Evaluation of 177Lu-TATE-EB-01（LNC1010）in SSTR2-positive Tumors (NCT05410743) | The First Affiliated Hospital of Xiamen University | 2022-06-01 |
| Neoadjuvant Chemoradiotherapy Followed by Sequential Immunotherapy for Thoracic Esophageal Squamous Cell Carcinoma (NCT06303583) | Qiu Guoqin | 2022-06-01 |
| HMPL-689 Drug Interaction Study With CYP3A Inhibitor/CYP2C9 Inhibitor/CYP3A Inducer/PPI (NCT05602597) | Hutchmed | 2022-06-01 |
| Transplantation of Neural Stem Cell-Derived Neurons for Parkinson's Disease (NCT03309514) | NeuroGeneration | 2022-06-01 |
| Investigating the Safety, Tolerability and Efficacy of Amorphous Calcium Carbonate (ACC) on the Treatment of Subjects With CRPC (NCT02864784) | Amorphical Ltd. | 2022-06-01 |
| Exploring Novel Uses of Microbiota Therapy for Managing the Side Effects of Psychiatric Pharmaceutical Interventions (NCT05022524) | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 2022-06-01 |
| Telehealth Virtual Reality Gaming on Cardiometabolic Health Among Youth With Cerebral Palsy (NCT05336227) | University of Alabama at Birmingham | 2022-06-01 |
| Study to Assess the Effect of Hepatic Impairment on the Pharmacokinetics of CTP-543 (NCT05467722) | Concert Pharmaceuticals | 2022-06-01 |
| A Phase 1 Dose-escalation Study of UGN-301 in Patients With Recurrent Non-muscle Invasive Bladder Cancer (NMIBC) (NCT05375903) | UroGen Pharma Ltd. | 2022-06-01 |
| Protective Effects of the Nutritional Supplement Sulforaphane on Doxorubicin-Associated Cardiac Dysfunction (NCT03934905) | Texas Tech University Health Sciences Center | 2022-06-01 |
| Effect of Poly Amido Amine Dendrimer, Nano-hydroxyapatite (NCT05771077) | Egymedicalpedia | 2022-06-01 |
| Phase 1 Study of BPI-442096 in Advanced Solid Tumor Patients (NCT05369312) | Betta Pharmaceuticals Co., Ltd. | 2022-06-01 |
| The Effect of Ketamine on Aesthetics and Role for Antidepressant Effects (NCT05320107) | Medical University of Vienna | 2022-06-01 |
| Application of Fecal Microbiota Transplantation in Children With ASD (NCT04948814) | Tongji Hospital | 2022-06-01 |
| Cicletanine in Hypertension With Diabetes: Added Magnesium Preserves Potassium and Sodium (NCT02709031) | Navitas Pharma | 2022-06-01 |
| Safety and Efficacy of Different Administration Sequences of L19TNF With Lomustine in Glioblastoma at First Progression (NCT05304663) | Philogen S.p.A. | 2022-06-01 |
| Azithromycin Versus Doxycycline on Restistin Level in Periodontitis Patients With Type 2 Diabetes (NCT06199440) | King Abdulaziz University | 2022-06-01 |
| 68Ga-NOTA-PEG2-RM26 PET/CT, First in Man Study (NCT06147362) | Karolinska University Hospital | 2022-06-01 |
| A Study of BL-M02D1 in Patients With Locally Advanced or Metastatic Gastrointestinal Tumors or Other Solid Tumors (NCT05385692) | Sichuan Baili Pharmaceutical Co., Ltd. | 2022-06-01 |
| A First-in-human of Multiplle Doses of BB-1705 in Subjects With Locally Advanced/Metastatic Solid Tumors (NCT05217693) | Bliss Biopharmaceutical (Hangzhou) Co., Ltd | 2022-06-01 |
| A Pilot Study of Neoadjuvant TACiE in Locally Advanced Gastric Cancer (NCT05396326) | Shanghai Zhongshan Hospital | 2022-06-01 |
| A Study of SARS-CoV-2 mRNA Vaccine (SYS6006) in Chinese Healthy Older Adults. (NCT05354063) | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 2022-06-01 |
| A Study of TQH2722 Injection to Evaluate the Safety, Tolerability, Pharmacokinetics, Efficacy and Immunogenicity in Healthy Adult Subjects (NCT05409326) | Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. | 2022-06-01 |
| A Study of mRNA-3745 in Adult and Pediatric Participants With Glycogen Storage Disease Type 1a (GSD1a) (NCT05095727) | ModernaTX, Inc. | 2022-06-01 |
| Modified Foot Exercise to Improve Sensitivity and Perfussion on Type 2 Diabetes Patients (NCT05408234) | Universitas Sebelas Maret | 2022-06-01 |
| Mechanisms of Diuretic Resistance in Heart Failure, Aim 1 (NCT05323487) | Yale University | 2022-06-01 |
| Atomoxetine and DAW2022 on OSA Severity (NCT05350215) | Brigham and Women's Hospital | 2022-06-01 |
| AB8939 in Patients With Relapsed/Refractory Acute Myeloid Leukemia (NCT05211570) | AB Science | 2022-06-01 |
| Phase I Clinical Trial of TQB3915 Tablets in Subjects With Advanced Malignant Solid Tumors (NCT05416359) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2022-06-01 |
| A Study of DZD8586 in Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma (TAI-SHAN1) (NCT05844956) | Dizal Pharmaceuticals | 2022-06-01 |
| TOPAZ: Tucatinib in COmbination With Pembrolizumab And TrastuZumab in Patients With HER2-Positive Breast Cancer Brain Metastases (NCT04512261) | Reva Basho | 2022-06-01 |
| Feasibility of Strategies to Increase SNAP Fruit and Vegetable Incentive Program Use for Families With Food Insecurity (NCT06593028) | University of South Carolina | 2022-06-01 |
| A Clinical Trial of COVAC-1, a COVID-19 Vaccine, in Generally Healthy Adults (NCT05155982) | University of Saskatchewan | 2022-06-01 |
| Improving Peptide Receptor Radionuclide Therapy With PARP Inhibitors (NCT05870423) | Erasmus Medical Center | 2022-06-01 |
| Gelatin Sponge VS PTFE Membrane for Socket Sealing After Immediate Implant Placement (NCT05982353) | Cairo University | 2022-06-01 |
| Study to Assess the Safety and Tolerability of ANG-3070 in Subjects With Idiopathic Pulmonary Fibrosis (NCT05387785) | Angion Biomedica Corp | 2022-06-01 |
| VIAging Deceleration Trial Using Metformin, Dasatinib, Rapamycin and Nutritional Supplements (NCT04994561) | Vitality in Aging Research Group, Inc. | 2022-06-01 |
| A Study to Evaluate the Efficacy and Safety of AK127 in Patients With Advanced Solid Tumors (NCT05393063) | Akeso | 2022-06-01 |
| CD19.CAR-multiVSTs for Patients With CD19+ B-ALL or NHL Undergoing Related Allogeneic HSCT (CARMA) (NCT03768310) | Baylor College of Medicine | 2022-06-01 |
| KurCoSmart Effects on People With Type 2 DM (NCT05407467) | Universitas Sebelas Maret | 2022-06-01 |
| Ketamine Infusion for Rapid Reduction of Suicidality in Pediatrics (NCT04955470) | University of British Columbia | 2022-06-01 |
| Investigation of Intranasal Ketamine Related Changes in Attentional Brain Networks With Functional and Structural MRI (NCT05320120) | Rupert Lanzenberger | 2022-06-01 |
| Study to Evaluate the Safety and Tolerability of TT-01488 in Patients With B-Cell Malignancies (NCT05275504) | TransThera Sciences (Nanjing), Inc. | 2022-06-01 |
| Fruquintinib Combined With Toripalimab and SOX Regimen in the First-line Treatment of Advanced Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma (NCT05024812) | The First Affiliated Hospital of Zhengzhou University | 2022-06-01 |
| CLDN6/GPC3/Mesothelin/AXL-CAR-NK Cell Therapy for Advanced Solid Tumors (NCT05410717) | Second Affiliated Hospital of Guangzhou Medical University | 2022-06-01 |
| Clinical Study of DMT in Healthy Adults (NCT05573568) | Biomind Labs Inc. | 2022-06-01 |
| Study of ORIC-944 in Patients With Metastatic Prostate Cancer (NCT05413421) | ORIC Pharmaceuticals | 2022-06-01 |
| Phase 1/2 Study of CD19 Chimeric Antigen Receptor T-cell (CD19 CAR-T; PL001) for Relapsed or Refractory B-cell Lymphoma (NCT05326243) | Pell Bio-Med Technology Co., Ltd. | 2022-05-31 |
| Study to Evaluate the Safety and Pharmacokinetics of CKD-331 (NCT05335044) | Chong Kun Dang Pharmaceutical | 2022-05-31 |
| A Study of the Safety, Tolerability and Effectiveness of EZM0414 (IPN60210) Investigative Product in Participants With Relapsed/Refractory Multiple Myeloma and Relapsed/Refractory Diffuse Large B Cell Lymphoma (NCT05121103) | Epizyme, Inc. | 2022-05-31 |
| A Study of ICP-189 and ICP-189 in Combination With Anti-PD-1 Monoclonal Antibody in Patients With Advanced Solid Tumors (NCT05370755) | Beijing InnoCare Pharma Tech Co., Ltd. | 2022-05-31 |
| Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS (NCT05379985) | Revolution Medicines, Inc. | 2022-05-31 |
| A Study of DS-9606a in Patients With Advanced Solid Tumors (NCT05394675) | Daiichi Sankyo | 2022-05-31 |
| A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG) (NCT05099003) | National Cancer Institute (NCI) | 2022-05-31 |
| A Pharmacodynamics and Safety Study of DSP-9632P in Patients With Levodopa-Induced Dyskinesia in Parkinson's Disease (NCT05435729) | Sumitomo Pharma Co., Ltd. | 2022-05-31 |
| Adoptive T Cell Therapy Following HER2-Pulsed Dendritic Cell Vaccine & Pepinemab /Trastuzumab in Patients w/ Metastatic HER2+ Breast Cancer (NCT05378464) | H. Lee Moffitt Cancer Center and Research Institute | 2022-05-31 |
| FT536 Monotherapy and in Combination With Monoclonal Antibodies in Advanced Solid Tumors (NCT05395052) | Fate Therapeutics | 2022-05-31 |
| A Study to Assess the New Candidate Rift Valley Fever Virus Vaccine in Healthy Adults (NCT04672824) | University of Oxford | 2022-05-31 |
| A Pharmacokinetic Study Comparing the 14028 Injection and TRULICITY® in Healthy Chinese Subjects (NCT05459285) | Sunshine Lake Pharma Co., Ltd. | 2022-05-31 |
| ACCENT: AMP945 in Combination With Nab-paclitaxel and Gemcitabine for Treatment of Pancreatic Cancer (NCT05355298) | Amplia Therapeutics Limited | 2022-05-31 |
| The Clinical Trial to Evaluate the Pharmacokinetics and Safety of MRTX849 in Patients With Advanced Solid Tumors (NCT05263986) | Zai Lab (Shanghai) Co., Ltd. | 2022-05-30 |
| MK-2060 and Clopidogrel Co-administration Safety and Tolerability Study in Participants With End-Stage Renal Disease (ESRD) (MK-2060-008) (NCT05335005) | Merck Sharp & Dohme LLC | 2022-05-30 |
| A Study of JNJ-80202135 in Healthy Chinese Adult Participants (NCT05151692) | Janssen Research & Development, LLC | 2022-05-30 |
| A Phase I/II Study to Evaluate the Safety, Pharmacokinetics and Efficacy of PRJ1-3024 in Subjects with Advanced Solid Tumors (NCT05315167) | Zhuhai Yufan Biotechnologies Co., Ltd | 2022-05-30 |
| A Thorough QT Study of Aticaprant (JNJ-67953964) in Healthy Adult Participants (NCT05387759) | Janssen Research & Development, LLC | 2022-05-30 |
| Safety and Immunogenicity Dose-finding Study of Adjuvanted SCB-2020S Vaccine in Adults (NCT05228314) | Clover Biopharmaceuticals AUS Pty | 2022-05-30 |
| Postoperative Experience of 2 WALANT-type Modes of Anesthesia Used in Ambulatory Surgery of the Upper Limb. (NCT05343299) | Centre Hospitalier Universitaire de Nīmes | 2022-05-30 |
| Treatment of Cabotamig (ARB202) in Advanced Gastrointestinal Cancer Patients (NCT05411133) | Arbele Pty Ltd | 2022-05-30 |
| A Research Study of How the Medicine Ziltivekimab Works in the Body of Chinese Men and Women With Kidney Disease and Inflammation (NCT05379829) | Novo Nordisk A/S | 2022-05-30 |
| A Clinical Study of CD70-targeted CAR-T in the Treatment of CD70-positive Advanced/Metastatic Solid Tumors (NCT05518253) | Weijia Fang, MD | 2022-05-30 |
| A Clinical Study of LM103 Injection in the Treatment of Advanced Solid Tumors (NCT05366478) | Suzhou BlueHorse Therapeutics Co., Ltd. | 2022-05-30 |
| A Study to Compare Onivyde Manufactured at Two Different Production Sites in Adult Participants With Advanced Cancer in the Pancreas (NCT05383352) | Ipsen | 2022-05-30 |
| S-531011 as Monotherapy and in Combination With an Immune Checkpoint Inhibitor in Advanced or Metastatic Solid Tumors (NCT05101070) | Shionogi | 2022-05-30 |
| Combination of Conditioned Medium and Umbilical Cord-Mesenchymal Stem Cells Therapy for Acute Stroke Infarct (NCT05008588) | PT. Prodia Stem Cell Indonesia | 2022-05-30 |
| Comparison of the Pharmacokinetic and Pharmacodynamic Properties of Biocon's Insulin R U-500 With Humulin® R U-500 (US Reference Product) in Healthy Subjects (NCT05413863) | Biocon Limited | 2022-05-30 |
| Bioequivalence Study of Solifenacin Succinate & Mirabegron From Mirfenacin MR 5/50 mg Extended Release Tablets (Hikma Pharma, Egypt) Versus Vesicare 5 mg FCT & Betmiga 50 mg Prolonged-Release Tablets (Astellas Pharma Europe B.V, the Netherlands / Astellas Pharma Europe B.V, the Netherlands) (NCT05767632) | Genuine Research Center, Egypt | 2022-05-30 |
| A TRIAL TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND EFFICACY OF SHR-A1904 IN SUBJECTS WITH ADVANCED SOLID TUMORS (NCT05277168) | Jiangsu HengRui Medicine Co., Ltd. | 2022-05-30 |
| A Study in Healthy Male Subjects to Investigate the Comparability of Pharmacokinetics of the Fixed-Dose Combination of Pertuzumab and Trastuzumab Administered Subcutaneously Using a Handheld Syringe or Using the On-Body Delivery System (NCT05275010) | Hoffmann-La Roche | 2022-05-30 |
| A Clinical Trial of Safety and Tolerance of TQH3821 Tablets in Adult Healthy Subjects (NCT05380934) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2022-05-29 |
| A Study to Evaluate the Effect of Different Meal Types on the Pharmacokinetics of DBPR108 in Healthy Subjects (NCT05150626) | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 2022-05-29 |
| OTL38 Injection (OTL38) for Intra-Operative Imaging of Folate Receptor Positive Ovarian Cancer (NCT04941378) | Abramson Cancer Center at Penn Medicine | 2022-05-28 |
| Teen Brain Training (TBT) (NCT06183580) | University of Minnesota | 2022-05-28 |
| Tucidinostat Plus Etoposide in the Treatment of Neuroblastoma in Childhood. (NCT05338541) | Yizhuo Zhang | 2022-05-27 |
| AsiDNA Children, Adolescents and Young Adults (NCT05394558) | Institut Curie | 2022-05-27 |
| A Study of Single-dose MY008211A in Healthy Adults (NCT05642585) | Wuhan Createrna Science and Technology Co., Ltd | 2022-05-27 |